CLINICAL_TRIALS
trial_result
· 2018-01-10
Clinical Trial Update: Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 trial results for GPX-150 in soft tissue sarcoma have been completed with posted results in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gem Pharmaceuticals | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2018-01-10